Irritable Bowel Syndrome News

Despite affecting nearly 10% of the population, irritable bowel syndrome remains highly stigmatized. During IBS Awareness Month, a gastrointestinal disease advocacy group has launched the #YouandIBS campaign to confront this stigma head on.

Colesevelam was superior to placebo in inducing remission in patients with bile acid diarrhea with no serious adverse events reported, according to results published in The Lancet Gastroenterology & Hepatology.

The FDA has granted priority review to a supplemental new drug application for Linzess for the treatment of functional constipation in patients aged 6 to17 years old, according to an Ironwood Pharmaceuticals press release.

Celltrion has submitted a biologics license application to the FDA for the consideration of a subcutaneous formulation of infliximab in the treatment of inflammatory bowel disease, according to a press release.

Specific and nonspecific acupoint acupuncture improved symptoms of diarrhea among a small subset of patients with irritable bowel syndrome, according to results from a pilot study reported in JAMA Network Open.

Irritable bowel syndrome may result from ineffective anatomical, physiological and neuropsychological gravity-management systems, a researcher theorized in an article published in The American Journal of Gastroenterology.

Chronic constipation affects up to 20% of adults and 16% of children in the U.S, therefore the International Foundation for Gastrointestinal Disorders recognized December as Constipation Awareness Month.

AbbVie announced that it has submitted a supplemental new drug application for Linzess for the treatment of functional constipation in patients aged 6 to 17 years, according to a press release.

The FDA has approved Idacio as the eighth biosimilar to adalimumab, for all eligible indications of the reference product, clearing the way for its U.S. release in 2023 alongside a deluge of other Humira biosimilars.

Disorders of gut-brain interaction cause symptoms throughout the digestive tract including pain, changes in bowel patterns, nausea, regurgitation or vomiting, which can be upsetting or embarrassing for children and teens